Literature DB >> 28539498

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment.

R M Anthony1, M Cynamon2, S Hoffner3, J Werngren4, A L den Hertog5, D van Soolingen6.   

Abstract

Entities:  

Keywords:  Mycobacterium tuberculosis; multidrug resistance; pyrazinamide

Mesh：

Substances：

Year:  2017        PMID： 28539498      PMCID： PMC5444118          DOI： 10.1128/AAC.00258-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China.

Authors:  Xubin Zheng; Rongrong Zheng; Yi Hu; Jim Werngren; Lina Davies Forsman; Mikael Mansjö; Biao Xu; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 2.  Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?

Authors:  Alice L den Hertog; Sarah Sengstake; Richard M Anthony
Journal:  Pathog Dis       Date:  2015-05-19       Impact factor: 3.166

3.  Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain.

Authors:  Vegard Eldholm; Johana Monteserin; Adrien Rieux; Beatriz Lopez; Benjamin Sobkowiak; Viviana Ritacco; Francois Balloux
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

4.  Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus.

Authors:  Kurt R Wollenberg; Christopher A Desjardins; Aksana Zalutskaya; Vervara Slodovnikova; Andrew J Oler; Mariam Quiñones; Thomas Abeel; Sinead B Chapman; Michael Tartakovsky; Andrei Gabrielian; Sven Hoffner; Aliaksandr Skrahin; Bruce W Birren; Alexander Rosenthal; Alena Skrahina; Ashlee M Earl
Journal:  J Clin Microbiol       Date:  2016-11-30       Impact factor: 5.948

5.  Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis.

Authors:  Michelle Yee; Pooja Gopal; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

6.  Evolution and transmission of drug-resistant tuberculosis in a Russian population.

Authors:  Nicola Casali; Vladyslav Nikolayevskyy; Yanina Balabanova; Simon R Harris; Olga Ignatyeva; Irina Kontsevaya; Jukka Corander; Josephine Bryant; Julian Parkhill; Sergey Nejentsev; Rolf D Horstmann; Timothy Brown; Francis Drobniewski
Journal:  Nat Genet       Date:  2014-01-26       Impact factor: 38.330

7.  A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis.

Authors:  Mariam O Fofana; Sourya Shrestha; Gwenan M Knight; Ted Cohen; Richard G White; Frank Cobelens; David W Dowdy
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.